These findings extend prior evidence on NO–sGC–cGMP signaling and offer mechanistic insights into the vascular origins of ischemic and hypertensive disease (Russo et al., 2024; Gawrys et al., 2025). This evidence concerns the gene SGCB and hypertensive disorder.